By
Drug Target Review2024-07-15T12:00:44
Researchers have developed a prediction model to ascertain breast cancer survivors’ risk of persistent taxane-induced peripheral neuropathy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-05-08T09:00:00
Contributor Ning Ren
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2023-02-07T15:25:20
Sponsored by Bio-Techne
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
Site powered by Webvision Cloud